Morimoto, T., Gandhi, T.K., Fiskio, J.M., Seger, A.C., So, J.W., Cook, E.F., Fukui, T. and Bates, D.W. (2004) An Evaluation of Risk Factors for Adverse Drug Events Associated with Angiotensin-Converting Enzyme Inhibitors. Journal of Evaluation in Clinical Practice, 10, 499-509.
https://doi.org/10.1111/j.1365-2753.2003.00484.x

has been cited by the following article:

• TITLE: About a Case of Neurotic Angioedema Induced by Angiotensin Converting Enzyme Inhibitor

  AUTHORS: Rakotoniaina Andriamiarimbola Irène, Fenomana Jocia, Riel Andry Mampionona, Rasamindrakotroka Andry

  KEYWORDS: Neurotic Angioedema, ACE inhibitor, Diagnosis, Treatment

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.6 No.11, November 15, 2017

  ABSTRACT: Neurotic angioedema may be secondary to ACE (Angiotensin-converting enzyme) inhibitor. From a case of neurotic angioedema in a hypertensive man under ACE (Angiotensin-converting enzyme) inhibitor, we expose the clinical characteristics typical of the edema and its evolution. A 73-year-old man has consulted for edema of the face and redness of the palmar surface of the hand not pruriginous for 2 days. He has already had conventional anti-edematous treatments but no changes. In the absence of a technical platform, no paraclinical examination was carried out. The cessation of ACE inhibitor and the administration of tranexamic acid were made immediately. Signs regressed within 24 hours. Neurotic angioedema is a diagnostic problem in countries where biological examination is still limited and if practitioners are unaware of the possibility of its occurrence during IEC treatment. While the patient’s prognosis depends on the precocity of management.